Medical Management – Sinuva, ASA Desensitization
Dr. Roland Gerencer offers a non-surgical procedure for patients who suffer from repeat nasal polyps with SINUVA (mometasone furoate) Sinus Implant. SINUVA is proven to reduce polyps and nasal congestion and obstruction.
What is SINUVA
SINUVA is a Sinus implant that treats nasal polyps without surgery. During a routine office visit, Dr. Gerencer will use topical and/or local anesthesia to numb the patient’s nose and sinuses. SINUVA is then placed in the Sinus cavity through the nasal opening.
How SINUVA works
Its innovative design provides a 2-in-1 approach: it is designed to open in the sinus cavity and release anti-inflammatory medicine to treat nasal polyps for up to 90 days.
SINUVA benefits (at 90 days):
- Significantly reduces nasal obstruction and congestion;
- Significantly improves the impaired sense of smell;
The most common adverse reaction observed in a clinical trial were bronchitis, upper respiratory middle year infection, headache, light headaches, asthma, and nose bleed. SINUVA is indicated for adults with nasal polyps who have had ethmoid sinus surgery.
1 – SINUVA Prescribing Information, Intersect ENT. December 2017.
2 – Data on files, Intersect ENT. Resolve II Rev. 3.0 CSR R 28017; February 2017.